Hemostemix Announces Ongoing Phase II CLI Trial Abstract Accepted for Presentation by Canadian Society for Vascular Surgery

World News: . []

CALGARY Alberta July 02 2019 GLOBE LINK  -- Hemostemix Inc or the TSX VENTURE HEM OTCQB HMTXF a biotechnology company developing and commercializing blood-derived stem cell LINK  for unmet medical conditions is pleased...

More news and information about Hemostemix Inc.

Published By:

Globe Newswire: 13:30 GMT Tuesday 2nd July 2019

Published: .

Search for other references to "hemostemix" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2020. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us